After raising new capital, veterinary medicine company Panion Animal Health AB is now ready to ramp up development of its treatment method for canine epilepsy. At the same time, discussions are under way for a licensing deal that could give Panion access to a new...
Panion Animal Health AB (publ) (“Panion”) has received approval for admission to trading of its shares on AktieTorget. The listing of Panion on AktieTorget facilitates distribution of CombiGene’s shares in Panion to CombiGene’s shareholders. The first day of trading...
The licensing agreement with CombiGene has recently been renegotiated. The revised agreement is now finalized and statements concerning CombiGene’s entitlement to withdrawal have been reformulated. Levels of remuneration to Panion in the event of a withdrawal have...
